Aeolus Announces Publication of Data Demonstrating Efficacy of AEOL 10150 in Animal Model of Lung Radiation Exposure; Models Developed for Pivotal Efficacy Studies
10 févr. 2014 07h30 HE
|
Aeolus Pharmaceuticals
MISSION VIEJO, CA--(Marketwired - Feb 10, 2014) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS)
Three papers published in Health Physics, Volume 106, Number 1 (January 2014)
...
Aeolus Receives Orphan Drug Designation for AEOL 10150 From U.S. FDA
23 janv. 2014 10h52 HE
|
Aeolus Pharmaceuticals
MISSION VIEJO, CA--(Marketwired - Jan 23, 2014) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS), a biotechnology company developing compounds to protect against radiological and chemical threats with...
Aeolus Announces Fiscal Year 2013 Financial Results
23 déc. 2013 08h00 HE
|
Aeolus Pharmaceuticals
MISSION VIEJO, CA--(Marketwired - Dec 23, 2013) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS), a biotechnology company developing compounds to protect against radiological and chemical threats with...
Aeolus Files Application for New Patent on AEOL 10150
05 déc. 2013 11h14 HE
|
Aeolus Pharmaceuticals
MISSION VIEJO, CA--(Marketwired - Dec 5, 2013) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS)
Filing covers synthesis, formulation and pharmaceutical composition
...
Radiation Detection, Monitoring & Safety Market for Nuclear Power Plants, Homeland Security & Defense, Manufacturing Industry
14 nov. 2013 09h48 HE
|
Research and Markets
Trends & Global Forecasts to 2017, Nov. 14, 2013 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/cv3wpm/radiation)
has announced the addition of the...
Radiation Therapy Equipment - Global Strategic Business Report 2012-2018
07 nov. 2013 09h40 HE
|
Research and Markets
Dublin, Nov. 7, 2013 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/2r75m2/radiation_therapy)
has announced the addition of the
"Radiation Therapy Equipment -...
Aeolus' AEOl 10150 Significantly Improves Survival and Protects Lungs in Mice Exposed to Lethal Radiation
29 oct. 2013 08h00 HE
|
Aeolus Pharmaceuticals
MISSION VIEJO, CA--(Marketwired - Oct 29, 2013) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS)
Optimal dose of AEOL 10150 improved survival by four times over untreated...
Radiation Cured Products: UV Cured Powder Coatings Emerge Victorious in Eco-Friendly Race
24 oct. 2013 07h27 HE
|
Research and Markets
Dublin, Oct. 24, 2013 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/f2pszs/radiation_cured)
has announced the addition of the
"Radiation Cured Products - Global...
BARDA Exercises $6.0MM in Additional Contract Funding for Development of AEOL-10150 as Treatment for Acute Radiation Syndrome
17 sept. 2013 13h30 HE
|
Aeolus Pharmaceuticals
MISSION VIEJO, CA--(Marketwired - Sep 17, 2013) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS)
BARDA exercise options valued at $6.0 million effective September 16, 2013...
AVX RELEASES NEW TRANSGUARD(r) & STATICGUARD MULTILAYER VARISTORS WITH TIN/LEAD TERMINATIONS
17 sept. 2013 11h05 HE
|
AVX Corporation
GREENVILLE, S.C., Sept. 17, 2013 (GLOBE NEWSWIRE) -- AVX Corporation, a leading manufacturer of advanced passive components and interconnect solutions, has released the new TransGuard® and...